Clinical Trial Update: Platelet Reactivity After Receiving Clopidogrel Among Moderate CKD Patients Undergoing PCI

View source ↗

Summary

This clinical trial update examines platelet reactivity after clopidogrel in patients with moderate chronic kidney disease undergoing percutaneous coronary inte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Ruqiong Nie | Conditions: Coronary Heart Disease | Status: UNKNOWN